Central Trust CO Novavax Inc Transaction History

Central Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$3.76 - $6.02 $22 - $36	6 Added 6.0%	106 $0
Q1 2022 May 03, 2022	SELL	$69.73 - $142.9 $2,370 - $4,858	-34 Reduced 25.37%	100 $7,000
Q2 2021 Jul 23, 2021	BUY	$121.0 - $257.67 $4,114 - $8,760	34 Added 34.0%	134 $28,000
Q3 2020 Oct 22, 2020	BUY	$79.44 - $178.51 $7,944 - $17,851	100 New	100 $10,000

287

94.7M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $689M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Trust CO with notifications on news.